How sleep patterns and disruptions affect heart health in African-Americans
Multilevel Determinants of Circadian Factors and Sleep Disruption: Implications for Cardiometabolic Health Among African-Americans
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-10903964
This study is looking at how sleep problems and changes in our body clocks affect heart and metabolic health in African-Americans, especially in Atlanta, and it wants to understand how different life factors and personal strength can help improve these health issues.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10903964 on ClinicalTrials.gov |
What this research studies
This research investigates how disruptions in sleep and circadian rhythms impact cardiometabolic health specifically among African-Americans. It aims to understand the socio-environmental factors that contribute to these disruptions and how they relate to health outcomes like blood pressure and metabolism. By studying a diverse group of African-Americans in Atlanta, the research will explore the role of individual resilience in mitigating these effects. The approach includes repeated measures to gather comprehensive data over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are African-American individuals experiencing sleep disruptions or disorders, particularly those living in socioeconomically diverse environments.
Not a fit: Patients who do not identify as African-American or those without sleep-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that improve sleep quality and overall heart health in African-American communities.
How similar studies have performed: Previous research has shown that addressing sleep disorders can significantly improve health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JOHNSON, DAYNA — EMORY UNIVERSITY
- Study coordinator: JOHNSON, DAYNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.